Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming
Authors
Keywords
-
Journal
GENES & DEVELOPMENT
Volume 31, Issue 22, Pages 2235-2249
Publisher
Cold Spring Harbor Laboratory
Online
2017-12-22
DOI
10.1101/gad.305631.117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
- (2017) Rinath Jeselsohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation
- (2017) Dedra H. Fagan et al. Hormones & Cancer
- mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
- (2015) Govindasamy-Muralidharan Karthik et al. CANCER LETTERS
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- Differential Requirements for eIF4E Dose in Normal Development and Cancer
- (2015) Morgan L. Truitt et al. CELL
- Subnuclear domain proteins in cancer cells support the functions of RUNX2 in the DNA damage response
- (2015) S. Yang et al. JOURNAL OF CELL SCIENCE
- Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells
- (2015) Lindsey Decarlo et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Runx2 contributes to the regenerative potential of the mammary epithelium
- (2015) Nicola Ferrari et al. Scientific Reports
- Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts
- (2014) P. Cottu et al. CLINICAL CANCER RESEARCH
- RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland
- (2014) L. McDonald et al. Disease Models & Mechanisms
- A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer
- (2014) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
- (2014) Andrew L. Wolfe et al. NATURE
- eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
- (2014) Lise Boussemart et al. NATURE
- Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
- (2014) N Robichaud et al. ONCOGENE
- The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor
- (2014) Kristen L. Karlin et al. Cell Reports
- Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis
- (2014) Hai Wu et al. GENOME BIOLOGY
- Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
- (2013) Howard A. Burris CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The p53-Estrogen Receptor Loop in Cancer
- (2013) C. Berger et al. CURRENT MOLECULAR MEDICINE
- Tamoxifen resistance: From bench to bedside
- (2013) Marjolein Droog et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer
- (2013) Sharmilee Bansal Korets et al. GYNECOLOGIC ONCOLOGY
- Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: Implications for tumor angiogenesis
- (2013) Janice García-Quiroz et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
- (2012) Josefine Bostner et al. BREAST CANCER RESEARCH AND TREATMENT
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- The RUNX family in breast cancer: relationships with estrogen signaling
- (2012) N-O Chimge et al. ONCOGENE
- DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs
- (2012) M. Badura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
- (2012) Atsushi Sato et al. Nature Communications
- Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases
- (2011) B. W. Konicek et al. CANCER RESEARCH
- Translational Control by the Eukaryotic Ribosome
- (2011) Ivan Topisirovic et al. CELL
- Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
- (2011) Todd W. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Runx2 in normal tissues and cancer cells: A developing story
- (2010) Karen Blyth et al. BLOOD CELLS MOLECULES AND DISEASES
- MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity
- (2010) Euphemia Leung et al. CANCER BIOLOGY & THERAPY
- The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival
- (2010) Matthew J. Wheater et al. CANCER BIOLOGY & THERAPY
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
- (2010) Andrew C. Hsieh et al. CANCER CELL
- High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance
- (2010) N. E. Simpson et al. CANCER RESEARCH
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitotic Raptor Promotes mTORC1 Activity, G2/M Cell Cycle Progression, and Internal Ribosome Entry Site-Mediated mRNA Translation
- (2010) F. Ramirez-Valle et al. MOLECULAR AND CELLULAR BIOLOGY
- Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance
- (2010) Gauri Sabnis et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Eukaryotic Initiation Factor 4E Binding Protein Family of Proteins: Sentinels at a Translational Control Checkpoint in Lung Tumor Defense
- (2009) Y. Y. Kim et al. CANCER RESEARCH
- Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
- (2009) J. Pratap et al. CANCER RESEARCH
- mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation
- (2009) Rachel L. Yamnik et al. FEBS LETTERS
- Regulation of Protein Synthesis by Ionizing Radiation
- (2009) S. Braunstein et al. MOLECULAR AND CELLULAR BIOLOGY
- An oestrogen-receptor-α-bound human chromatin interactome
- (2009) Melissa J. Fullwood et al. NATURE
- Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
- (2009) Deborah Silvera et al. NATURE CELL BIOLOGY
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
- (2008) Andrea Bianchini et al. CARCINOGENESIS
- eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
- (2008) Francisco Ramírez-Valle et al. JOURNAL OF CELL BIOLOGY
- MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
- (2007) Robert M. Rowlett et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started